These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8794984)

  • 21. Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel.
    Al-Kassas R; Wen J; Cheng AE; Kim AM; Liu SSM; Yu J
    Carbohydr Polym; 2016 Nov; 153():176-186. PubMed ID: 27561485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum.
    Ryu JM; Chung SJ; Lee MH; Kim CK; ShimCK
    J Control Release; 1999 May; 59(2):163-72. PubMed ID: 10332051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal delivery of beta-blockers.
    Aqil M; Sultana Y; Ali A
    Expert Opin Drug Deliv; 2006 May; 3(3):405-18. PubMed ID: 16640500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic study into the enhanced transdermal permeation of a model beta-blocker, propranolol, by fatty acids: a melting point depression effect.
    Stott PW; Williams AC; Barry BW
    Int J Pharm; 2001 May; 219(1-2):161-76. PubMed ID: 11337176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
    Kshirsagar SJ; Bhalekar MR; Mohapatra SK
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Influence of Formulation and Excipients on Propranolol Skin Permeation and Retention.
    Padula C; Nicoli S; Pescina S; Santi P
    Biomed Res Int; 2018; 2018():1281673. PubMed ID: 30175113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation preparation of L-arginine/acrylic acid hydrogel matrix patch for transdermal delivery of propranolol HCl in hypertensive rats.
    Radwan RR; Mohamed HA; Ali HE; Mahmoud GA
    Drug Deliv Transl Res; 2018 Jun; 8(3):525-535. PubMed ID: 29313295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride.
    Thacharodi D; Rao KP
    Biomaterials; 1995 Jan; 16(2):145-8. PubMed ID: 7734649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The increased intestinal absorption rate is responsible for the reduced hepatic first-pass extraction of propranolol in rats with cisplatin-induced renal dysfunction.
    Okabe H; Mizukami A; Taguchi M; Aiba T; Yasuhara M; Hashimoto Y
    J Pharm Pharmacol; 2003 Apr; 55(4):479-86. PubMed ID: 12803769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal therapeutic system of isradipine: effect of hydrophilic and hydrophobic matrix on in vitro and ex vivo characteristics.
    Tirunagari M; Jangala VR; Khagga M; Gannu R
    Arch Pharm Res; 2010 Jul; 33(7):1025-33. PubMed ID: 20661712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin irritation in transdermal drug delivery systems: a strategy for its reduction.
    Kawahara K; Tojo K
    Pharm Res; 2007 Feb; 24(2):399-408. PubMed ID: 17191093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transdermal drug delivery systems of a beta blocker: design, in vitro, and in vivo characterization.
    Aqil M; Sultana Y; Ali A; Dubey K; Najmi AK; Pillai KK
    Drug Deliv; 2004; 11(1):27-31. PubMed ID: 15168788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal delivery of mepindolol and propranolol in normal man. 2nd communication: pharmacokinetic and neuro-endocrine aspects.
    de Mey C; Meineke I; Enterling D; Rehbock C; Osterwald H
    Arzneimittelforschung; 1989 Nov; 39(11A):1508-12. PubMed ID: 2576201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The pharmacokinetics of propranolol when used with the propercuten transdermal therapeutic system (experimental data)].
    Piotrovskiĭ VK; Belolipetskaia VG; Vasil'ev AE; Shorr VA; Chichenkov ON; Fel'dshteĭn MM; Metelitsa VI
    Eksp Klin Farmakol; 1993; 56(6):53-6. PubMed ID: 8111301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crosslinked polyvinylalcohol hydrogels as vehicles for hydrophilic drugs.
    Orienti I; Di Pietra A; Luppi B; Zecchi V
    Arch Pharm (Weinheim); 2000 Dec; 333(12):421-4. PubMed ID: 11199472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled transdermal delivery of propranolol using HPMC matrices: design and in-vitro and in-vivo evaluation.
    Verma PR; Iyer SS
    J Pharm Pharmacol; 2000 Feb; 52(2):151-6. PubMed ID: 10714944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel transdermal delivery of Timolol maleate using sugar esters: preclinical and clinical studies.
    El-Laithy HM
    Eur J Pharm Biopharm; 2009 May; 72(1):239-45. PubMed ID: 19126429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use.
    Amnuaikit C; Ikeuchi I; Ogawara K; Higaki K; Kimura T
    Int J Pharm; 2005 Jan; 289(1-2):167-78. PubMed ID: 15652209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and local safety profile of propranolol eye drops in rabbits.
    Padrini L; Isacchi B; Bilia AR; Pini A; Lanzi C; Masini E; Della Bona ML; Calvani AM; Ceccantini R; la Marca G; Filippi L
    Pediatr Res; 2014 Oct; 76(4):378-85. PubMed ID: 25029260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.